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ABSTRACT The CLC family of chloride channels and transporters is a functionally diverse group of proteins important in a
wide range of physiological processes. ClC-4 and ClC-5 are localized to endosomes and seem to play roles in the acidiﬁcation
of these compartments. These proteins were recently shown to function as Cl/H1 antiporters. However, relatively little is
known about the detailed mechanism of CLC-mediated Cl/H1 antiport, especially for mammalian isoforms. We attempted to
identify molecular tools that might be useful in probing structure-function relationships in these proteins. Here, we record
currents from human ClC-4 (hClC-4) expressed in Xenopus oocytes, and ﬁnd that Zn21 inhibits these currents, with an apparent
afﬁnity of ;50 mM. Although Cd21 has a similar effect, Co21 and Mn21 do not inhibit hClC-4 currents. In contrast, the effect of
Zn21 on the ClC-0 channel, Zn21-mediated inhibition of hClC-4 is minimally voltage-dependent, suggesting an extracellular
binding site for the ion. Nine candidate external residues were tested; only mutations of three consecutive histidine residues,
located in a single extracellular loop, signiﬁcantly reduced the effect of Zn21, with one of these making a larger contribution than
the other two. An analogous tri-His sequence is absent from ClC-0, suggesting a fundamentally different inhibitory mechanism
for the ion on hClC-4. Manipulations that alter transport properties of hClC-4, varying permeant ions as well as mutating the
‘‘gating glutamate’’, dramatically affect Zn21 inhibition, suggesting the involvement of a heretofore unexplored part of the protein
in the transport process.
INTRODUCTION
The CLCs represent a homologous group of Cl transport
proteins that play important roles in many physiological as
well as pathological processes. Though all known CLCs
transport Cl across membranes, fundamental aspects of the
transport mechanism vary dramatically between members.
A striking example of this functional diversity is the obser-
vation that some CLCs function as chloride ion channels,
whereas others are coupled proton/chloride antiporters.
ClC-3, -4, and -5 are members of a highly homologous
CLC subfamily primarily found in intracellular organelles
(1). ClC-5 has been demonstrated to contribute to endosomal
acidiﬁcation in kidney (2), with loss-of-function mutations
leading to the defects of proximal tubule solute resorption
known as Dent’s disease in humans (3). Though ClC-4 has
been suggested to play a similar role (4), details of its
physiology and mechanism remain unclear. Though ionic
currents through ClC-4 and ClC-5 were ﬁrst observed a de-
cade ago (5), only recently were both ClC-4 and -5 shown to
be Cl/H1 antiporters (6,7), as was ClC-7 (8). Given the high
homology (77%) within the CLC 3/4/5 subfamily, ClC-3
likely functions in a similar manner, though this protein has
recently been also proposed to function as a chloride channel
(9). The observations that ClC-4 and -5 are antiporters rather
than ion channels imply that these proteins operate by fun-
damentally different mechanisms than their channel cousins,
like ClC-0 and ClC-1. These proteins are also relatively
distantly related to the prototypical CLC transporter ClC-ec1,
suggesting that they may also demonstrate signiﬁcant func-
tional divergence from the bacterial transporter, with differ-
ences in both voltage dependence and ion coupling (10).
Thus, biophysical understanding of these transporters re-
quires independent analysis of the CLC-3/4/5 subfamily.
Several properties of mammalian CLC antiporters make
mechanistic analysis difﬁcult. First, no high afﬁnity inhibi-
tors are known for these proteins. Such inhibitors serve as
valuable tools for probing structure and function in transport
proteins. Second, ClC-4 and -5 currents display an extreme
outward rectiﬁcation when heterologously expressed (5),
making reversal potentials impossible to measure. Without
access to this property, it is difﬁcult to address permeation
and ion coupling in these proteins. Thus, development of
novel tools to investigate the mechanistic features of these
proteins is essential. One set of tools that has been useful in
previous studies of CLC structure and function are divalent
metal ions.
Divalent cations are known to interact with many mem-
brane proteins, including members of the CLC family. For
example, Zn21 has been shown to inhibit currents from the
channel CLCs, ClC-0, -1, and -2 (11–13). Studies of Zn21
inhibition in ClC-0 reveal that zinc inhibits currents by
preferentially binding to and stabilizing the closed state of the
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slow gate, one of the two gating mechanisms described in
these channels (11). Lin et al. showed that this effect can be
reduced by mutating a cysteine residue (C212) that is vital for
slow gating (14), which corresponds to the extracellular end
of helix G in the ClC-ec1 structure (15). Recent evidence also
suggests that native Xenopus oocyte Cl currents, proposed
to represent xClC-5 currents (16), display sensitivity to Zn21.
Here we demonstrate that Zn21 inhibits currents from
human ClC-4 heterologously expressed in Xenopus oocytes,
and that it operates with an action strikingly different from its
effect on the ClC-0 channel. Zn21 has a moderate apparent
afﬁnity and its interaction with hClC-4 is minimally voltage-
dependent, indicating an extracellular binding site. Muta-
tional analysis identiﬁes three residues, distant from the site
corresponding to C212 in ClC-0, which reduce the Zn21 ef-
fect. Surprisingly, mutation of the ‘‘gating glutamate’’,
which uncouples Cl and H1 transport and is distant from the
likely binding site, completely abolishes the effect of Zn21.
Furthermore, the effects of Zn21 vary with the identity of the
permeant anion. These observations suggest conformational
coupling between the Zn21 binding site and the ion perme-
ation pathway.
MATERIALS AND METHODS
An expressed sequence tag (GenBank accession No. AA282953), coding for
a full-length humanClC-4 cDNA,was cloned into the pBluescript SK vector.
Though our sequence differs from the original hClC-4 GenBank sequence
(accession number X77197), it is identical to the updated sequence (acces-
sion number NM_001830). Mutations were made using the Quickchange
site-directed mutagenesis kit (Stratagene, La Jolla, CA), and veriﬁed by the
DNA sequencing facility National Institute of Neurological Disorders and
Stroke. Each mutant was sequenced fully, to ensure the absence of undesired
mutations. RNA was transcribed in vitro using the mMessage mMachine T3
RNA polymerase kit (Ambion, Austin, TX).
ClC-4 was expressed in Xenopus oocytes, and currents were measured
using a two-electrode voltage clamp with an OC-725C oocyte ampliﬁer
(Warner Instrument, Hamden, CT), and digitized using a Digidata 1321A
interface and pCLAMP 9 software (Axon Instruments, Foster City, CA).
Glass electrodes were pulled to resistances between.3–1 MV. Bath clamp
electrodes were connected to wells containing 3 M KCl, and these were
connected to the recording bath by 3-M KCl/agar bridges. Recordings were
performed at room temperature in ND96 solution (96 mMNaCl, 2 mMKCl,
1.8 mM CaCl2, 1 mMMgCl2, and 5 mM HEPES, pH 7.4), unless otherwise
stated. Recording solutions were perfused into the chamber by gravity ﬂow.
Divalent cations were added to the ND96 solution as chloride salts at the
desired concentration. For anion substitution experiments, 80 mMNaCl was
replaced with 80 mM NaBr, NaNO3, or NaI.
Two voltage protocols were used to explore properties of wild-type (WT)
and mutant hClC-4. To monitor expression and determine current-voltage
relations, families of current traces were elicited by stepping from a35-mV
holding potential to voltages between50 mV and190 mV, each followed
by a short test pulse to 80 mV. To screen for effects from divalent cations,
we used identical repeated depolarizations to 160 mV for 300 ms, starting
from a holding potential of40mV. For all experiments, multiple batches of
oocytes were examined. An entire batch of oocytes was discarded if unin-
jected cells from that batch had signiﬁcant anion currents. Zn21 measure-
ments were bracketed by measurements in the absence of Zn21, and
discarded if the inhibition was irreversible; this only occurred with [Zn21].
10 mM, rendering experiments impracticable at these concentrations.
Dose-response data were ﬁt with a Hill equation, y ¼ ðImaxxn=Kn0:51xnÞ;
where Imax is the maximum inhibition, n is the Hill coefﬁcient, and K0.5 is the
concentration for half-maximal inhibition. Signiﬁcance tests utilize the
Student’s t-test. For all measurements, N ¼ 3–10, and error bars indicate the
mean 6 SE. Error bars are not shown when they are smaller than the sym-
bols. Structures were rendered using PyMOL (DeLano Scientiﬁc, Palo Alto,
CA).
RESULTS
Though hClC-4 is primarily an endosomal protein not nor-
mally expressed on the cell surface, upon overexpression in
Xenopus oocytes, a signiﬁcant number of transporters pop-
ulate the cell membrane and can mediate ionic currents. The
currents we observe are similar to those previously described
(Fig. 1 A) (5,17,18): they are very strongly outwardly recti-
fying, displaying little or no inward current. Upon depolari-
zation, hClC-4 currents exhibit two phases of activation: a
fast component, which is already complete by the end of the
capacitive transient, as well as a slower activation, on a mil-
lisecond timescale, which can be clearly seen in the current
traces at positive voltages (Fig. 1 A). The extremely strong
rectiﬁcation provides a useful estimate of the amount of leak
in a given oocyte, and the rectiﬁcation remained strong in all
tested permeant anions. Since the leaks we observe are linear,
any signiﬁcant inward current reﬂects contamination of the
heterologously expressed hClC-4 current.We did not observe
strong outward rectifying currents similar to hClC-4 in any
FIGURE 1 Zn21 inhibition of hClC-4 currents. (A and B) hClC-4 currents
measured in Xenopus oocytes with two-electrode voltage clamp in the absence
(A) and presence (B) of 100mMzinc.Voltagewasheld at35mV, pulsed from
50 to190 in steps of 20mV, and then to80mVbefore returning to holding
potential. (C) Steady-state current responses to varying concentrations of
extracellular zinc. Oocytes were held at40mV and pulsed repeatedly to160
mV (circles) every 1 s. Solutions containing indicated concentrations (in mM)
of ZnCl2 were perfused into the chamber as indicated by bars; otherwise,
chamber was perfused with ND96. Zinc inhibition was fully reversible in all
cases. (D) Dose-response curve for ClC-4 at160mV, plotted on a logarithmic
scale. For this and subsequent ﬁgures, error bars represent standard error of the
mean (N $ 3); when not shown, they are smaller than the symbols. Data are
ﬁtted with the Hill equation (K0.5 ¼ 52 mM, n ¼ 0.58, Imax¼ 63%).
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uninjected oocytes. This is consistent with the observations of
Reyes et al. (16); they observed an outwardly rectifying en-
dogenous oocyte current in some anions, but when Cl was
the current carrier, the current was minimal. To further rule
out contamination of measured currents by endogenous Cl
channels, we recorded currents from uninjected oocytes in
every batch of oocytes used in this study. The entire batch was
discarded if substantial endogenous currents were present.
Extracellular Zn21 inhibits outwardly rectifying hClC-4
currents (Fig. 1, A and B). Currents are elicited under constant
perfusion; Zn21 is introduced and washed out at a constant
ﬂow rate. Onset of inhibition takes place within the solution-
exchange timescale for our perfusion system (seconds).
Washout is slower, and is prolonged at higher Zn21 concen-
trations (Fig. 1C). Upon washout, currents return faithfully to
their pre-Zn21 levels (at [Zn21] up to ;10 mM), demon-
strating that Zn21 inhibition is fully reversible in this con-
centration range. Zn21 inhibition is dose-dependent, with
maximal current reductions of ;60%, leaving a signiﬁcant
residual current. The residual current clearly reﬂects ion ﬂux
through hClC-4 since the full rectiﬁcation of the current is
maintained even at 1 mM Zn21: we see no evidence of in-
creased leak. Zn21 levels above 10 mM damage oocyte
membranes, creating erratic responses to stimulation and
making experiments at higher concentrations infeasible. The
dose-response curve for Zn21 is well ﬁt by a Hill equation
(r2¼ 0.9986), yielding an apparent afﬁnity of;50mM, and a
Hill coefﬁcient of ;0.6. Cd21 inhibits hClC-4 with similar
dose-response properties compared with those of Zn21,
whereasMn21 andCo21 have no effect (Fig. 2,A andB) up to
concentrations of 1 mM. The variable effects of different di-
valent metal ions reveal that the mechanism of inhibition by
Zn21 andCd21 cannot reﬂect simple electrostatic effect, since
all four ions should screen surface charges on the protein to
similar extents. Because the effects of Zn21 and Cd21 are so
similar, we concentrated on the Zn21 effect for further char-
acterization.
We examined the voltage dependence of Zn21 inhibition
by comparing the effects of the ion at a series of positive
potentials. Measurements at negative voltages could not be
made because of the extreme rectiﬁcation of the transporter.
For a given oocyte, we measured the instantaneous and
steady-state current at a series of voltages, then repeated these
measurements in the presence of 100mMZn21, followed by a
third set of measurements after removing Zn21 to verify the
reversibility of inhibition. Steady-state current-voltage rela-
tions in the presence and absence of 100 mMZn21 are shown
for a typical oocyte in Fig. 3 A. Plotting the fractional inhi-
bition as a function of voltage (Fig. 3 B) demonstrates that the
Zn21 effect is minimally dependent on membrane potential
over the measurable range of voltages. Zn21 has a similarly
negligible effect on the voltage dependence of the instanta-
neous component of the hCLC-4 current (Fig. 3 B). Thus,
Zn21 is unlikely to traverse a signiﬁcant fraction of the trans-
membrane voltage as it accesses its binding site on hClC-4:
it probably binds at or near the extracellular surface of the
transporter.
In ClC-0 and ClC-1, Zn21 inhibition is strongly reduced
by mutation of a conserved cysteine residue, C212 in ClC-0,
which also plays a key role in the slow gating of this channel
(14). However, there is no Cys residue in the analogous po-
sition on the hClC-4 gene, suggesting different coordinating
residues, and perhaps a distinct mechanism of inhibition, for
Zn21 on hClC-4. Since Zn21 usually binds proteins through
interactions with cysteine and histidine moieties (19), we
attempted to identify the Zn21 binding site by focusing on
these residues as candidate Zn21 coordinating sites. Because
of the minimal voltage dependence of Zn21 inhibition, we
examined residues predicted to lie on the extracellular side of
the protein, as determined using the sequence alignment of
hClC-4 and ClC-ec1 and a transmembrane topology derived
from the ClC-ec1 crystal structure. Four histidine and ﬁve
cysteine residues met these criteria (Fig. 4 A). We mutated
each of these residues in turn, and screened the mutant
transporters for changes in Zn21 sensitivity that might reﬂect
disruption of a metal binding site.
All mutants except C405S express and produce currents
similar to WT in the absence of Zn21. Mutations of three
candidate residues affected Zn21 inhibition: removing each
of three sequential His residues, located on the extracellular
FIGURE 2 Effect of other divalent cations on hClC-4 currents. (A) Steady-
state inhibition of currents by 100 mM extracellular Cd21, Co21, or Mn21 at
150-mV holding potential, normalized to current in ND96. (B) Dose-
response curve for extracellular Cd21 (solid symbols, solid line), compared
with dose-response curve for Zn21 (open symbols, gray line; same data as
shown in Fig. 1D), both at160mV. Fit parameters for Cd21:K0.5¼ 68mM,
n ¼ 0.58, Imax ¼ 69%.
FIGURE 3 Voltage dependence of Zn21 effect. (A) Representative I/V
curves for steady-state hClC-4 currents plotted in absence (solid circles) or
presence (open circles) of 100mMZn21. (B) Ratio of inhibited to uninhibited
current in 100 mM Zn21, plotted as a function of voltage. Values are plotted
for instantaneous (open triangles) and steady-state (solid circles) currents.
Experimental points are connected with straight line segments.
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loop between helices N and O (Fig. 4 A), produces a signif-
icant reduction in Zn21 inhibition at 100 mM (Fig. 4 B).
Comparing the dose-response curves of mutants with WT,
we ﬁnd that H494A and H495A each shifts the apparent afﬁnity
of the Zn21 site by a small amount (Fig. 4C; H494A,K0.5¼ 95
mM; H495A, K0.5 ¼ 103 mM), with saturation expected at the
same level of inhibition as WT (63%). The mutation H493A
has a more dramatic effect (Fig. 4 C). Although we were
unable to observe complete saturation of inhibition for H493A
in our range of usable Zn21 concentrations, an unconstrained
ﬁt with a Hill equation yields a similar maximal inhibition to
WT (71%), with the apparent afﬁnity shifted by a factor of
26 (K0.5 ¼ 1.33 mM). Alternatively, if we constrain the
Hill equation ﬁt to a maximal inhibition of 62.7%, i.e., the
WT value, we ﬁnd the afﬁnity shifted ;12-fold (K0.5 ¼ 651
mM). Regardless of the detailed, model-dependent parame-
ters of the ﬁt, it is clear that the H493A mutation causes a shift
of the Zn21 dose-response corresponding to a considerable re-
duction in apparent afﬁnity. Mutations of all remaining candi-
date extracellular Zn21-binding residues resulted in proteins
displaying Zn21 sensitivities similar to wild-type (Fig. 4 B).
The strong effect of mutating H493, combined with the
smaller effects of alterations atH494 andH495, suggest that these
residuesmight combine to form theZn21 binding site in hClC-4.
If so, simultaneous mutations eliminating all three histidines
might eliminate the site and the effect of Zn21. To test this
hypothesis, we constructed proteins with all three histidines
removed, or with each of the three possible pairs of His mu-
tants. Of these, only H493A/H495A yields currents upon func-
tional expression; it displays Zn21 sensitivity almost identical
to the single mutant H493A (1.33 mM; Fig. 4D, H493A, purple
trace; H493A/H495A, green trace), suggesting that H495 does
not make a major contribution to residual Zn21 binding in the
H493A mutant. Neither of the other combinations of double
mutants (H493A/H494A or H494A/H495A) or the triple mutant
(H493A/H494A/H495A) expresses functionally in oocytes.
By analyzing an alignment between the protein sequence
of hClC-4 and that of ClC-ec1, whose structure is known, we
ﬁnd that the residues apparently responsible for the Zn21
binding site (H493, H494, and H495) align with residues at the
N-terminus of the extracellular loop connecting helix N to
helix O in the ClC-ec1 structure (ClC-ec1, residues 381–383)
(20). Interestingly, helix N projects into the core of the pro-
tein, and contributes main-chain hydrogen bonds to one of
the bound Cl ions (at Scen) and to the side chain of the gating
glutamate (E148; see Fig. 7). If the hClC-4 structure is similar
to that of the Escherichia coli protein, then this observation
suggests a mechanism of Zn21 inhibition: Zn21 binding
could constrain a movement of helix N required for transport.
This hypothesis predicts that there should be interactions
between Cl binding and Zn21 binding.
To test this hypothesis, we performed manipulations that
could affect the occupancy of the Cl binding site. First, we
mutated the hClC-4 residue corresponding to the ‘‘gating
glutamate’’ in ClC-ec1 (21). In ClC-ec1 and ClC-5, neu-
tralizing this conserved glutamate removes coupling between
Cl and H1 (6,7,22). As previously observed, the equivalent
mutation in hClC-4 (E224A) removes the rectiﬁcation, and
causes the protein to become a nearly linear Cl leak (Fig. 5 A)
(5). Surprisingly, removing the hClC-4 gating glutamate
also abolishes the inhibitory effect of Zn21 at concentrations
up to 1 mM. The 100-mM effect is shown in Fig. 5 B (black
open circles); the linear conductance caused by the E224A
mutant (solid circles) is clearly different from the leak in
uninjected oocytes (gray circles). This result is consistent
with a model in which the chemical environment near the
inner end of helix N projects to the relatively distant Zn21
through movements of this helix.
FIGURE 4 Mutation scan for Zn21-binding residues. (A)
Extracellular and solvent-accessible cysteine and histidine
residues in hClC-4, mapped onto ClC-ec1 topology. Can-
didate Zn21 coordinating His (red circles) and Cys (purple
circles) residues are shown. Green circle represents gating
glutamate for reference. (B) Effect of 100 mM Zn21 on
mutants of candidate Zn21-coordination sites, expressed as
percentage of WT inhibition by 100 mM Zn21 at 160 mV.
(C) Dose-response curves at 160 mV of single histidine
mutants H493A (purple triangles and line), H494A (blue
squares and line), and H495A (orange diamonds and line);
WT dose response is shown for comparison (gray circles
and line). (D) Dose-response curve of double mutant H493A/
H495A at 160 mV (green triangles and line), shown with
those for H493A (purple) and WT (gray) for comparison. Fit
parameters: H493A (constrained, see text), K0.5 ¼ 590 mM,
n ¼ 0.44, Imax ¼ 63%; H494A, K0.5 ¼ 95 mM, n ¼ 0.52,
Imax¼ 64%; H495A, K0.5¼ 103 mM, n¼ 0.52, Imax¼ 62%;
H493A/H495A, K0.5 ¼ 590 mM, n ¼ 0.39, Imax ¼ 61%.
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We further tested this model by varying the identity of the
permeant ion, another manipulation that could affect oc-
cupancy of the hClC-4 anion binding sites. Current levels
for hClC-4 are known to vary with the permeant ion, with
NO3 . Cl
 . Br ; I (5) (Fig. 6 A). When changing
external anions, we sometimes observe an endogenous
current similar to that described by Reyes et al. (16).
However, it usually activates at stronger depolarizations
than the heterologous current and is thus easily detected.
Only when I was the current carrier did we observe con-
sistent interfering endogenous currents. Because of these,
we could not reliably measure hClC-4 currents 160 mV
(note omission of these points in Fig. 6 A). We ﬁnd that the
degree of inhibition by 100 mM Zn21 similarly varies as the
permeant ion shifted; Zn21 causes a greater inhibition when
NO3 is the permeant ion than when Cl
 carries current (Fig.
6 B). (We veriﬁed that the inhibition reached a steady-state
level by ﬁtting the decay to a falling exponential plus a
constant term; the constant term never differed from the data
by more than 2.3%.) Indeed, the sequence of inhibitory
effects is NO3 . Cl
 . Br ; I. Plotting the fractional
inhibition against the relative current in the different anions,
we ﬁnd an apparent correlation, with the data lying clustered
around a line of slope 1 (Fig. 6 C). Ions that carry large
currents through the transporter also exhibit large inhibition
by Zn21, again consistent with the hypothesis that the
N-helix mediates interactions between permeant ions and
Zn21 binding.
DISCUSSION
Our results agree with previous studies of hClC-4 that describe
characteristic, strongly outwardly rectifying currents with a
conduction sequence of NO3 . Cl
 . Br  I. Here we
report that human ClC-4 is inhibited by Zn21, with a maximal
inhibition of;65% and an apparent afﬁnity in the micromolar
range. Although Zn21 inhibition is characterized in other
CLCs and in native outwardly rectifying chloride currents in
Xenopus oocytes (16), to our knowledge, this is the ﬁrst ob-
servation of a Zn21 effect on a known CLC antiporter. Zn21
inhibition is minimally voltage-dependent, suggesting that the
metal ion acts near the extracellular face of the membrane.
FIGURE 5 Gating glutamate mutant loses Zn21 sensitivity. (A) Current
traces from Xenopus oocytes express gating glutamate E224A mutant. (B)
Steady-state I/V curves for E224A mutant in absence (solid circles) or
presence (open circles) of 100 mM Zn21. For comparison, gray circles
indicate currents measured in control uninjected oocytes.
FIGURE 6 Interactions between anion permeation and Zn21 inhibition. (A)
I/V curves for WT ClC-4 in different external anions: Cl (maroon circles),
I (mustard squares), Br (orange downward triangles), and NO3 (green
diamonds). Data are normalized to current measured in Cl at 160 mV. (B)
Inhibition byZn21 in different anions. A representative oocytewas held at40
mV and pulsed repeatedly to 160 mV during application on 100 mM ZnCl2
in presence of 96 mM external Cl (maroon circles); the oocyte was then
perfused sequentially with solutions replacing 80 mM Cl with an equal con-
centration of I (mustard squares), Br (orange downward triangles), or NO3
(green diamonds). To allow comparison of degree of inhibition, currents were
normalized to their value in each anion before addition of Zn21. In each case,
they returned to baseline upon washout of Zn21. Black bar indicates time of
Zn21 exposure for Cl, Br, and I . Because of slower equilibration kinetics
in NO3 ; oocytes were exposed to Zn
21 for a longer time (green bar). (C)
Correlation between current levels and extent of Zn21 inhibition in varying
anions. Currents measured at160 mV in each anion are normalized to current
in Cl at that voltage. Relative inhibition represents fractional inhibition
measured for each anion, again normalized to the value for chloride.
4672 Osteen and Mindell
Biophysical Journal 95(10) 4668–4675
Mutations of three extracellular histidine residues inﬂuence,
but do not abolish this inhibition. Unexpectedly, manipula-
tions that alter coupled ion transport, including mutation of the
gating glutamate and variations of permeant anions, signiﬁ-
cantly inﬂuence the inhibitory effect of Zn21.
Zn21 inhibits the CLC channels ClC-0, -1, and -2, pre-
sumably through a common mechanism. This inhibition was
explored extensively for ClC-0, where Zn21 inhibits by sta-
bilizing the channel’s slow gate in its closed state (11). A point
mutation that abolishes slow gating signiﬁcantly reduces the
Zn21 effect in ClC-0 (14). Though this mutation removes a
cysteine, it remains unclear whether its effects result from
weakened Zn21 binding due to the removal of a coordinating
residue, or simply from the disruption of the slow gating
process in the context of preserved Zn21 binding. Either way,
we consider it unlikely that the binding site we identiﬁed in
hClC-4 is analogous to a Zn21 binding site in ClC-0, because
the residues that inﬂuence hClC-4 Zn21 binding site are not
conserved in ClC-0, and are not replaced by other candidate
Zn21-binding amino acids. Thus, it seems likely that Zn21
inhibition in hClC-4 represents a distinct mechanism.
An unusual feature of hClC-4’s inhibition by Zn21 is its
low Hill coefﬁcient of ;0.6. Though the classical explana-
tion for such a low Hill coefﬁcient would be a negatively
cooperative binding reaction, several other possibilities must
also be considered. Negative cooperativity implies an inter-
action between multiple binding sites, where binding at one
site decreases the binding afﬁnity of an alternate site. This
may be a possibility for hClC-4, given that the dimeric nature
of the transporter implies the presence of at least two binding
sites. However, studies of subunit interactions in ClC anti-
porters have not unearthed any signiﬁcant intersubunit in-
teractions as part of the transport process (10,23). An alternate
explanation for a Hill coefﬁcient ,1 is the presence of elec-
trostatic interactions. Such a situation might arise if, in addi-
tion to speciﬁc binding, Zn21 is nonspeciﬁcally concentrated
at the surface of the protein by its net negative surface charge.
Increasing concentrations of Zn21would substantially screen
the surface charge on the protein, and might interfere with
binding of the ion at the speciﬁc site. This would effectively
ﬂatten out the dose response and result in a low Hill coefﬁ-
cient. A third possibility is that we are observing the effects of
Zn21 binding at several sites with distinct but similar afﬁni-
ties. Further experiments will be required to distinguish
among these possibilities.
Of the known protein Zn21 coordination sites, the majority
consist of some combination of cysteine and histidine moi-
eties (though the acidic residues aspartate and glutamate are
also implicated in some Zn21 coordination sites) (19). Since
the apparent afﬁnity of the Zn21 site in hClC-4 is on the order
of 50 mM, the Zn21 binding site probably includes contri-
butions frommultiple amino acid side chains. Given the large
reduction in Zn21 afﬁnity with mutation of H493, it likely
plays a major role in Zn21 binding, whereas H494 and H495
may participate to a lesser degree. Though we were at ﬁrst
surprised to ﬁnd that three sequential His residues affect Zn21
binding, experience with binding of His-tagged proteins to
metal-chelating columns suggests that such sequential resi-
dues can contribute to metal afﬁnity (24). In addition, the
small effects of the latter two may reﬂect a less intimate co-
ordination than that of H493. The double mutant H493A/H495A
behaves very similarly to the single mutant H493A, which is
not unexpected, given that H493 seems to be the major residue
involved in Zn21 coordination. Because we could not express
the triple mutant or the other two combinations of double
mutants, we cannot conclusively rule out involvement by
another, more distant, coordinating residue.
Although no structure is available for a mammalian CLC,
the structure of an E. coliCLC homolog (ClC-ec1) has served
as a useful framework for these proteins (25,26). Likely
similar in overall structure to a CLC channel, the ClC-ec1
structure is probably an especially good model for hClC-4
transport since it functions as a Cl/H1 exchanger. We used a
sequence alignment of hClC-4 and ClC-ec1 to map the pu-
tative Zn21 binding site onto the ClC-ec1 crystal structure,
and ﬁnd that the three histidine residues reside on an extra-
cellular loop just above the N-helix. Though this loop is 12
amino acids longer in hClC-4, and there is no equivalent tri-
His motif in ClC-ec1, our alignment places the histidines just
after the top of the N-helix (Fig. 7 A). This helix projects to
the extracellular side of the transporter from the core of the
protein, where conserved residues at its amino terminus
contribute to the coordination of Cl ions at the Scen and Sext
binding sites (21) (Fig. 7 B). This area, adjacent to the
‘‘gating glutamate’’, is essential for H1/Cl coupling.
We propose that Zn21 binding near the top of the N-helix
transmits a conformational change along the helix that can
FIGURE 7 N-helix protrudes into core of permeation pathway and inter-
acts with both Cl and H1 binding sites. (A) Side-view of ClC-ec1. Mapped
locations corresponding to H493, H494, and H495 of ClC-4 are highlighted in
red. N-helix is shown in cyan. Approximate location of membrane boundary
is indicated. (B) Bottom of N-helix (cyan) is shown, highlighting its in-
teractions with central Cl binding site Scen and gating glutamate (orange).
Main-chain hydrogen bonds between N-helix residues and Glutamate148 and
Clcen are shown as black dotted lines. Hydrogen bonds between Tyr
445 and
Clcen; and between Ser
107 and Clcen; are also indicated. The central bound
Cl (Clcen) is shown as a yellow sphere. Side chains of Tyr
445, Ser107, and
Glu148 are shown for reference. This view is from the dimer interface, with
the four interfacial helices removed for clarity. Distances are in angstroms;
structure is 1OTS from the Protein Data Bank (15).
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couple interactions of the protein with permeant anions (or
protons) to those between the protein and Zn21. This model
comports well with our data showing that mutation of the
gating glutamate has a profound effect on Zn21 sensitivity, as
the same conformational change could transmit between the
protein core and the Zn21 binding site. The observation that
the Zn21 effect is modulated by changing the permeant anion
further supports this model, since we would expect, if Zn21
indirectly interacts with anion binding through the N-helix,
that the effect of this interaction would change based on the
binding properties of the permeant anion. Alternatively,
Zn21 could interact not by affecting anion binding but
through effects on the coupling between protons and anions.
This would suggest an effect of Zn21 not on the anion
binding site, but on the coupling mechanism itself. Though
the coupling ratios of protons with multiple halide ions have
not been accurately measured for a mammalian CLC anti-
porter, coupling is qualitatively impaired when NO3 is the
current carrier (10). This could explain some of our obser-
vations. Further experiments will be required to distinguish
whether Zn21 affects ion binding or proton coupling (or
some other alternative), and to examine the nature and extent
of the conformational change that mediates communication
between the Zn21 site and the transport pathway.
Zn21 proves to be a valuable tool to probe structure and
function of CLC transport, but may also represent a physio-
logical role for hClC-4 in intracellular Zn21 homeostasis.
Although total cellular Zn21 concentrations amount to 100–
500 mM, unbound cytoplasmic concentrations of the ion are
in the nanomolar range (27). Althoughmuch of the remaining
cellular Zn21 is bound to proteins as a cofactor in enzymatic
reactions, Zn21 may also be stored at much higher concen-
trations in vesicular compartments, including endosomes
or late endosomes (28,29). These compartments contain
speciﬁc Zn21 transporters, and may serve to regulate cyto-
plasmic Zn21 levels by sequestering excess Zn21 in the en-
dosomal lumen, especially in the face of toxic extracellular
Zn21 concentrations. Since the charge movement associated
with Zn21 transport would need to be neutralized, we specu-
late that hClC-4 could serve this role by moving a Cl coun-
terion. In this light, perhaps the Zn21 inhibition of hClC-4
reported here could play a role in the regulation of endosomal
Zn21 uptake.
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